Efficient dairy-beef production relies on good quality of purchased calves, defined by breed, health, and growth 15 characteristics. Several management factors, such as commingling of calves and large group size, predispose 16 calves to diseases. Acute phase proteins are sensitive detectors of calf diseases. We studied the associations 17 between group size, serum acute phase proteins, immunoglobulin G (IgG), calf morbidity and growth of dairy-18 beef calves in a random field trial in a calf-rearing unit in Finland. 19
Introduction 40
Optimal growth is essential for sustainable beef production. Growth is an aggregate of internal and external 41 factors that promote and retard growth, including balanced nutrition, genetics, stress and disease. Beef breeds 42 are bred specifically for particular growth and carcass quality characteristics. In the Nordic countries beef 43 production is largely from dairy cattle, so such quality traits have also been explored in dairy bulls (Johansson 44 et al., 2009), although as yet little used in beef production in Finland. 45
Diseases represent the major cause of decreased growth rate in young calves (Virtala et al., 1996; Windeyer et 46 al., 2014) , which are prone to infectious diseases (Svensson et al., 2003) due to immature immune systems, 47 low humoral antibody concentration and exposure to a number of stressors at an early age (Hulbert and Moisá, 48 2016) . Rearing a calf group of diverse origin increases morbidity (Step et al., 2008) increasing the profuse use 49 of antimicrobials at the rearing unit and a risk of lower daily gain. In addition to commingled groups, large 50 group size is another factor increasing morbidity (Svensson et al., 2003; Abdelfattah et al., 2015) . Considering 51 group size, smaller groups appear healthier (Svensson and Liberg, 2006; Abdelfattah et al., 2015) , but the 52 optimal group size with respect to health and labour has yet to be determined. 53
In Central Europe and North America (USA and Canada) veal calf production relies on collecting calves from 54 various dairy farms to rearing units, resulting in high morbidity and treatment rate, often with group treatment 55 In Finland, beef production is mainly based on raising bull calves of either dairy breeds or dairy × beef breed 61 crosses (mostly Blonde d'Aquitaine, Hereford, Aberdeen Angus, or Limousin) on separated beef farms until 62 15-18 months of age. Approximately two thirds of calves are delivered first to specialized calf-rearing units 63 and after that, at approximately six months of age, to specialized beef production farms. One third is delivered 64 from dairy farms directly to integrated beef production farms specialized in rearing, fattening and finishing the 65 purchased cattle. After the milk or starter feeding period of up to two months, feeding is based on silage 66 (approximately 60% of dry weight) and concentrate. All the bull calves and some surplus heifers are reared 67 for beef production. Calves are collected from several dairy farms and transported immediately to rearing units 68 at around 2-3 weeks of age, predisposing them to conditions similar to those for European veal production. 69
Usually calves are not vaccinated against bovine respiratory diseases in Finland, partly because Finland is free 70 from infectious bovine rhinotraceitis and bovine viral diarrhoea virus (Evira Finnish Food Safety Authority, 71
2016). 72 73
Acute phase proteins such as haptoglobin (Hp), serum amyloid A (SAA) and fibrinogen (Fb) are non-specific 74 markers of inflammation and diseases indicators (Petersen et al., 2004) , whose concentration increase with 75 respiratory tract infections umbilical diseases and diarrhoea in calves (Humblet et al., 2004; Nikunen et al., 76 and immunoglobulin G (IgG) samples were analyzed using commercial ELISA kit (Bio-X Diagnostics, 149
Rochefort, Belgium). 150 151

Statistical analysis 152
Linear mixed regression models were used to study the association of group size, calves' inflammatory status 153 on arrival, and medications with average daily gain for different time periods. Three mixed effect linear 154 regression models with variables EARLY, 200DAYS and carcass weight at SLAUGHTER as outcomes were 155 built, where batch and pen inside the batch were included as random effects. For these models, antimicrobial 156 treatment starting dates 7 days apart were considered as separate treatment series; all the treatments starting 157 less than 7 days apart were combined and considered as treatment of the same disease. Recurrence of a disease 158 was recorded when an antimicrobial treatment was re-introduced ≥8 days after the previous antimicrobial 159 treatment. Independent variables "age on arrival" in days, "group size" (large or small), albumin (g/l), globulin 160 (g/l), SAA (mg/l) and Hp (mg/l) concentration on day 0, "number of NSAID use only" (no concurrent 161 antimicrobial treatment), "number of antimicrobial treatments" (categories of 0-1, 2-3 or ≥4 times), gender, 162 and breed (Ayrshire, Holstein-Friesian or dairy-beef breed mix) were inserted to the models. Age at the time 163 of slaughter were included in the model with outcome variable as carcass weight at slaughter to control the 164 possible confounding effect of different rearing period. Confounding was defined as a change of 15% in 165 variable coefficients. 166
The final models were produced by backward elimination of the variables from the full model until all the 167 variables had p-values of <0.05, or when the Wald test for categorical variables with more than two categories 168 resulted in a p-value of <0.05. The variable "Age on arrival" was included in all the models where SAA was 169 included, to control for the association of age observed in SAA (Orro et al., 2008) . Group size was included in 170 all models as the main variable of the study design. Linear relations of the outcome variables and continuous 171 variables were checked and continuous variables were categorized if non-linear relationships were encountered 172 (in the case of number of antimicrobial treatments in EARLY model). Biologically meaningful interactions 173 were tested in all three models and no interactions were evident. The model fit was visually assessed using 174 scatter and normality plots of model residuals. 175
A multilevel mixed-effects parametric survival Weibull distribution model was used to assess the factors 176 associated with the time from arrival to first antimicrobial treatment. The following period started at calf arrival 177 at the rearing unit, and ended when the event of interest had occurred or when the data were right censored 178 when calves moved to another compartment at approximately on day 49. Two models were built; the events 179 of interests were the first antimicrobial treatment and the recurrence after the first antimicrobial treatment. all the variables had a p < 0.05. Group size was included in both survival models as a possible confounder. 186
Because some calves were medicated on arrival day, according to instructions of the herd veterinarian, and 187 examined one day after arrival, they had the first antimicrobial treatment on day -1. To produce positive time 188 integers, 2 days were added to the raw data. Six calves died of unknown causes before weaning and as 189 information about recurrence after the first antimicrobial treatment was missing for three of those calves, those 190 data were not included in the second model. Proportional hazard assumption and fit of survival models were 191 checked with log-log plots of survival and cumulative hazard vs. Cox-Snell residual plots, respectively. The majority of the calves (82.8%) were male. The average daily gains for three different time periods for each 201 breed and gender are presented in Table 1 . The mean weight at arrival was 55.7 kg (SD ± 10.2 kg), 58.0 kg 202 (SD ± 10.0 kg) and 55.2 kg (SD ± 9.7 kg) for Ay, Hol and mixed dairy beef breed. 203
On average, calves in the small groups originated from 7.2 herds (range 5-9 herds) and calves in large groups 204 from 23.8 herds (range 16-31 herds) per batch. There were no differences between the distribution of gender 205 in small and large groups. Considering breeds, in batch 4 there were more mixed breed calves in small groups 206 and more Holsteins in the large groups. Other batches showed no differences between the breeds in groups. 207
Mean age at arrival was greater in batch 5 in calves of the small group (mean age 29.3 days) than in large 208 groups (mean age 22.9 days), in other batches no difference was recorded. Mean weight at arrival was greater 209 in batches 4 and 5 in small groups (60.8 kg and 59.4 kg, respectively) than in large groups (55.4 kg and 51.8 210 kg, respectively), but other batches showed no differences in mean weight of the groups. 211
212
Use of medication 213
A total of 1417 records of antimicrobial treatment were collected during the 49-day rearing period (resulting 214 in 23,132 calf days). The major indication for antimicrobial treatment was respiratory disease, representing 215 88.6% of the treatment indications. The second most common indication was diarrhoea, representing 3.7% of 216 the treatments. Other indications were problems with lethargy (3.5%), feet (1.0%), colic (0.8 %), ear infections 217 or drooping ears (0.6%), umbilical diseases (0.4%), fever (0.2%), and undefined (1.2%). Combining 218 antimicrobial treatments administered within seven days into a single treatment resulted in 998 treatments 219 administered to 458 calves, and 18 calves (3.8%) untreated with antimicrobials during the 49-day rearing 220 period. For respiratory infections and other than diarrhoea tulathromycin, oxytetracycline, florphenicol and 221 procaine penicillin were used. Trimethoprime-sulphadoxine was used for calves with diarrhoea, when 222 necessary. Recurring infections were common, affecting 69.9% of the calves. The mean time for the first 223 recurrence of a disease was 26 days (SD ± 10.1 days) from arrival. The numbers for antimicrobial treatment 224 times are shown in Table 2 . Mean number of antimicrobial treatments for calf was 2.10 (SD ± 1.01) times. 225
The calves treated with NSAIDs only (1,347 NSAID treatments) had either signs of respiratory disease (93.3%) 226 or lethargy (5.5%), criteria for NSAID only use described in material and methods. Sporadic cases of problems 227 with feet, colic, diarrhoea or miscellaneous indications were also treated with NSAID only. Mean number of 228 treatments with NSAIDs only for calf was 2.77 (SD ± 2.45) and median 2 (min-max 0-14). 229
The factors related to the time before the first antimicrobial administration and the time to the first recurrence 230
were examined for the survival analysis. Higher IgG and albumin concentrations on day 0 lengthened the time 231 before the first antimicrobial treatment and the time to first recurrence (Table 3A and 3B). Calves of mixed 232 breed had longer times to the first antimicrobial treatment and recurrence than Ay calves (Table 3A and 3B) . 233
Hp and SAA concentration on day 0, age on arrival, group size and gender were not associated with the time 234 before the first medication or recurrence. Half of the calves (49.9%) had their first antimicrobial treatment in 235 the rearing unit by day 8 of the study, and 89.2% of the calves by day 21 (Figure 1) . By day 21, 26.8% of the 236 calves had already had a recurrence of a disease. 237
238
APP and IgG concentrations 239
The mean SAA and Hp concentrations at arrival were 61.4 mg/l (SD ± 37.1), median 52.4 mg/l (min-max 2.1-240 296.5) and 177 mg/l (SD ± 123), median 152 mg/l (min-max 60-1468), respectively. The mean albumin and 241
IgG concentrations at arrival were 33.8 g/l (SD ± 2.8) and 8.3 g/l (SD ± 4.5), respectively. 
Factors associated with growth 250
The regression models for growth (Table 4) detected several factors associated with the average daily gain at 251 different stages of calves' lives, but no difference in growth was detected between the small and large groups. 252
Bull calves grew faster than heifer calves over all periods. Ay calves had lower average daily gains than Hol 253 calves in EARLY and 200DAYS models, on average -60 g/day and -34 g/day, respectively. However, calves 254 of mixed breed had the highest carcass weight at SLAUGHTER, on average +18.3 kg compared with the Ay, 255
while there was no difference between Ay and Hol breeds in the SLAUGHTER model. The calves that were 256 older on arrival at the rearing unit had better average daily gains in EARLY and 200DAYS models. 257
In the EARLY model for rearing period of 49 days (Table 4A) , the use of only pain medication was negatively 258 associated with average daily gain, with an average decrease of 8.8 g/day each time pain medication was 259 administered without antimicrobial treatment. In contrast, antimicrobial treatments over 4 times were 260 associated with higher daily gain (on average 84 g/day) compared with calves treated with antimicrobials 0-1 261 times during the milk-feed period. 262
Increased SAA concentrations at day 0 were associated with lower average daily gain for both periods; a 50 263 mg/l increase in SAA concentration would be associated with a 30 and 19 g/day decrease in average daily gain 264 in EARLY and 200DAY models and 6 kg lower carcass weight at SLAUGHTER model, respectively (Table  265 4A, 4B, and Table 5 ). Increased IgG concentrations at day 0 were associated with better average daily gain in 266 EARLY growth (Table 4A ). Increased Hp concentration on day 0 was positively, and increased albumin 267 concentration (day 0) negatively associated with carcass weight at slaughter (Table 5) .
Group size 271
No differences between small and large groups were detected in this study regarding the number of 272 antimicrobial treatments or average daily gain. The small and large groups shared the same air space, resulting 273 in similar infection pressure for the both groups. The randomization of the group increased commingling and 274 calves from the same source farm ended up in different groups, resulting in increased stress and presentation 275 of new pathogen strains. A common practice is to attempt to maintain calves from the same source farm 276 together. These two aspects, together with a comparatively large group size also in the smaller groups, may be 277 the main factors for the absence of differences. 278
The optimal group size for calves, economically and health-wise, has not yet been defined. In our study the 279 groups of 4 x 10 and 40 calves were easy to form because of the compartment layout and farm routines. Group 280 size of >10 calves is also a reported risk factor for metaphylaxis administration (Lava et al., 2016b) . Frequency 281 of coughing or clinical respiratory tract disease increases as size of the calf group increases from 2 to 6-9 and 
Use of antimicrobials 290
Although metaphylactic group treatments were not used on the study farm, antimicrobials were extensively 291 used and only a few calves were left untreated during the milk-feeding period. Very precise follow-up and 292 measurement of the temperature of every calf, when even only slightly suspected, could have contributed to 293 the extensive antimicrobial usage, although NSAIDs alone were used for mildly sick calves with elevated 294 temperature. Antimicrobials were used in our study mostly to treat respiratory disease, similarly as for calves 295 in Denmark (Fertner et were male, for which the care on source farms is sometimes questioned. However, at least a study on Canadian 307 farmers reported that 91% of the farmers administered colostrum to all male calves (Renaud et al., 2017) . in the survival analysis models, and age does not explain the observed association. 316
The concentrations of other APPs were not associated with elapsed time to antimicrobial treatments. The 317 concentrations of SAA were moderate overall, but several increased concentrations of Hp were recorded. The 318 treatments of the calves began on the day of arrival, indicating that the disease originated from the dairy farm, 319 and the peak of the APPs might have already passed. The signs of disease can escalate following transport and 320 commingling with unknown animals, promoting an increased number of antimicrobial treatments soon after 321 arrival. The proportion of calves remaining untreated decreases steeply for the first two weeks, after which the 322 cases become less frequent, as also the number of animals at risk diminishes. The shape of the recurrence 323 survival curve differs from that for the first treatments in being less steep. The recurrence variable does not 324 take into account calves that have extended periods under antibiotics, without an eight-day period untreated. 325
326
Factors associated with daily gain 327
Bulls showed better average daily gains at all stages. For the first months Hol calves had better average daily 328 gains than Ay calves, which was reported previously for heifer calves (Lee et al., 1988; Pietersma et al., 2006) . 329
However, in the current study the difference between breeds was recorded only for the bulls. The beef breeds 330 by definition grow better than the calves of dairy breeds and this was also the case for the mixed breed calves. 331
The calf's age on arrival at the rearing unit was positively associated with better average daily gains over all 332 time periods, although the magnitude of association clearly diminished after the initial rearing period (EARLY 333 model). Older calves are at an advantage in a calf group where the feed resources and rest area may be limited. 334
In addition, the concentrations of IgG start increasing around 5-6 weeks of age, providing the calf with better 335 resistance to diseases (Klinkon et al., 2008; Hulbert and Moisá, 2016) . The relatively large variation in age of 336 the calves on arrival was due to fluctuation in demand and supply of calves, combined with transport 337 arrangements, when distance from farm to farm can be long. 338
The calves that received four to five antimicrobial treatments had better average daily gain during the milk 339 feed period than calves with fewer treatments, but the use of NSAID without a concurrent antimicrobial 340 treatment was negatively associated with the daily gain, although the cases were supposed to be less severe. 341
These somewhat controversial associations can be explained by: 1) The growth-promoting effect of 342 antimicrobials in production animals, which was reported in the 1950s, reviewed by Dibner and Richards 343 higher SAA at arrival were still lower. This is in contrary to the negative effect of morbidity (measured by 354 numbered of NSAID treatments) during the early rearing period. Those calves with higher morbidity 355 compensated for their weight loss and this early negative effect disappeared by age of 200 days and at 356
slaughter. 357
According to regularly used farm budgeting tables the effect is in economic terms extremely important when 358 it is causes an estimated 50 % drop in profit per calf in a calf-rearing unit. According to our results, the overall 359 association between SAA and growth is moderate for the beef production chain: two calves differing by 50 360 mg/l in SAA concentrations at the beginning of rearing, slaughtered at the age of 16 months would have a 361 carcass weight difference of 6 kg. The association of increased SAA in early life with growth rate over the 362 concentrations, the higher SAA concentration itself does not lead to poor average daily gain, but only reflects 377 a background factor associated with both increased SAA concentration and poorer average daily gain. 378
The increased concentration of globulin on arrival was associated with good average daily gain during the milk 379 feed period. Calves with IgG < 7.5 g/l had lower average daily gain in early growth than calves with IgG > 380 7.5 g/l in a Belgian study (Pardon et al., 2015) , similarly to our study. gain. The increase of acute phase protein serum amyloid A in the early life of a calf was associated with poorer 397 average daily gain for all the periods measured, including at slaughter at 15 to 18 months of age. Although the 398 mechanism for this association was not explained, it seems that events in a calf's early life can have long-399 lasting changes on the average daily gain. Complex relationships among morbidity, treatment protocols and 400 daily gain of calves were described. Whether regular screening of serum proteins -serum amyloid A, albumin 401
and IgG -would be economically profitable or not requires further exploration. calves before the first antimicrobial treatment time (black line) and before the first recurrence (grey line) during 598 the follow-up period, based on the survival models (Table 3A, B) . 599
